Tanshinone IIA reverses the malignant phenotype of SGC7901 gastric cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 1, 2013, Pages 173-177

  Xu, Min ^a   Cao, Fa Le ^a   Li, Nai Yi ^a   Liu, Yong Qiang ^a   Li, Yan Peng ^a   Lv, Chun Lei ^a  

^a 88th Hospital of PLA   (China)

Author keywords

Chemo; Gastric cancer; Growth; Invasion; Migration; Sensitivity; Tanshinone IIA

Indexed keywords

EID: 84877110567     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.1.173     Document Type: Article

References (33)

1. Alberts SR, Cervantes A, van de Velde CJ (2003). Gastric cancer: epidemiology, pathology and treatment. Ann Oncol, 14, i31-6.
2. Choi HS, Cho DI, Choi HK, et al (2004). Molecular mechanisms of inhibitory activities of tanshinones on lipopolysaccharide-induced nitric oxide generation in RAW 264.7 cells. Arch Pharm Res, 27, 1233-7.
3. Correa P (1992). Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res, 52, 6735-40.
4. Fu J, Huang H, Liu J, et al (2007). Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol, 568, 213-21.
5. Gao J, Yang G, Pi R, et al (2008). Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis. Transl Res, 151, 79-87.
6. Huang JY, Xu YY, Sun Z, et al (2012). Comparison Different Methods of Intraoperative and Intraperitoneal Chemotherapy for Patients with Gastric Cancer: A Meta-analysis. Asian Pac J Cancer Prev, 13, 4379-85.
7. IARC (2004). Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide, version 2.0. In IARC Cancer Base no. 5, Eds Ferlay J, Bray F, Pisani P, et al. IARC Press, Lyon, France.
8. Jiao JW, Wen F (2011). Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells. Oncol Rep, 25, 781-8.
9. Lam BY, Lo AC, Sun X, et al (2003). Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine, 10, 286-91.
10. Li L, Ying XJ, Sun TT, et al (2012). Overview of methodological quality of systematic reviews about gastric cancer risk and protective factors. Asian Pac J Cancer Prev, 13, 2069-79.
11. Liotta LA, Stetler-Stevenson WG (1991). Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res, 51, 5054s-9s.
12. Liu JJ, Lin DJ, Liu PQ, et al (2006). Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro. J Biomed Sci, 13, 813-23.
13. Lochhead P, El-Omar EM (2008). Gastric cancer. Br Med Bull, 85, 87-100.
14. Lu Q, Zhang P, Zhang X, et al (2009). Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer. Int J Mol Med, 24, 773-80.
15. Pan TL, Hung YC, Wang PW, et al (2010). Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells. Proteomics, 10, 914-29.
16. Parkin DM (2004). International variation. Oncogene, 23, 6329-40.
17. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
18. Parkin DM, Bray FI and Devesa SS (2001). Cancer burden in the year 2000. The global picture. Eur J Cancer, 37, S4-66.
19. Shi WT, Wei L, Xiang J, et al (2012). Chinese patients with gastric cancer need targeted adjuvant chemotherapy schemes. Asian Pac J Cancer Prev, 13, 5263-72.
20. Su CC, Chen GW, Kang JC, et al (2008). Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells. Planta Med, 74, 1357-62.
21. Su CC, Lin YH (2008). Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios. Int J Mol Med, 22, 357-61.
22. Wang AM, Sha SH, Lesniak W, et al (2003). Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother, 47, 1836-41.
23. Werner M, Becker KF, Keller G, et al (2001). Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol, 127, 207-16.
24. Won SH, Lee HJ, Jeong SJ, et al (2010). Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway. Biol Pharm Bull, 33, 1828-34.
25. Wu MS, Shun CT, Wang HP, et al (1997). Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology, 112, 1457-65.
26. Yang LJ, Jeng CJ, Kung HN, et al (2005). Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells. J Biomed Sci, 12, 347-61.
27. Yang R, Liu A, Ma X, et al (2008). Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation. J Cardiovasc Pharmacol, 51, 396-401.
28. Yasui W, Yokozaki H, Fujimoto J, et al (2000). Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol, 35, 111-5.
29. Yuan SL, Wei YQ, Wang XJ, et al (2004). Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol, 10, 2024-8.
30. Yuxian X, Feng T, Ren L, et al (2009). Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo. Tumori, 95, 789-95.
31. Zhang K, Li J, Meng W, et al (2010). C/EBPbeta and CHOP participate in tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro. Int J Hematol, 92, 571-8.
32. Zhou L, Zuo Z and Chow MS (2005). Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol, 45, 1345-59.
33. Zhou LH, Hu Q, Sui H, et al (2012). Tanshinone II-A Inhibits Angiogenesis through Down Regulation of COX-2 in Human Colorectal Cancer. Asian Pac J Cancer Prev, 13, 4453-8.